Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Clinical trial NCT04402788 · RECRUITING

Trial details

NCT number

NCT04402788

Sponsor

National Cancer Institute (NCI)

Status

RECRUITING

Phase

Phase 2, Phase 3

Study type

INTERVENTIONAL

Start date

2021-01-07

Primary completion

2027-04-30

Enrollment

138

View on ClinicalTrials.gov